Literature DB >> 3082112

The renin-angiotensin system in pregnancy and parturition.

F Alhenc-Gelas, A Tache, J P Saint-Andre, J Milliez, C Sureau, P Corvol, J Menard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3082112

Source DB:  PubMed          Journal:  Adv Nephrol Necker Hosp        ISSN： 0084-5957


× No keyword cloud information.
  6 in total

Review 1.  Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia.

Authors:  Yang Xia; Susan M Ramin; Rodney E Kellems
Journal:  Hypertension       Date:  2007-06-18       Impact factor: 10.190

2.  Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation.

Authors:  G Valdés; A M Germain; J Corthorn; C Berrios; A C Foradori; C M Ferrario; K B Brosnihan
Journal:  Endocrine       Date:  2001-11       Impact factor: 3.633

3.  Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.

Authors:  Cissy Chenyi Zhou; Shakil Ahmad; TieJuan Mi; Lingwei Xia; Shahrzad Abbasi; Peter W Hewett; ChunXiao Sun; Asif Ahmed; Rodney E Kellems; Yang Xia
Journal:  Circ Res       Date:  2006-12-07       Impact factor: 17.367

4.  Identification of Structural and Molecular Signatures Mediating Adaptive Changes in the Mouse Kidney in Response to Pregnancy.

Authors:  Jorge Lopez-Tello; Maria Angeles Jimenez-Martinez; Esteban Salazar-Petres; Ritik Patel; Amy L George; Richard G Kay; Amanda N Sferruzzi-Perri
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

Review 5.  Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies.

Authors:  Lauren Anton; K Bridget Brosnihan
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-10

6.  Regulator of G Protein Signaling 2 Facilitates Uterine Artery Adaptation During Pregnancy in Mice.

Authors:  Jennifer N Koch; Shelby A Dahlen; Elizabeth A Owens; Patrick Osei-Owusu
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.